OnKure Therapeutics, Inc.
USD4.50
+0.00 (+0.00%)
CEO
Nicholas A. Saccomano
IPO Date
2021-04-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.63
Prev. Close
$4.50
Day Low
$4.40
Day High
$4.71
52W Low
$1.91
52W High
$5.38
Market Cap
$0.06B
Volume
0.41M
| -2.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 34.7% | -98.8% | -0.01 | 4.64 | -6.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 54.2% | -184.5% | -0.01 | 2.46 | -10.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -27.0% | -25.8% | 0.00 | 24.79 | -3.9 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 46.2% | -35.2% | -2.20 | 12.01 | -19.4 |
| -0.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -22.1% | -20.2% | 0.01 | 11.45 | -0.6 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -19.7% | -17.9% | 0.01 | 11.13 | -0.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -17.6% | -15.9% | 0.01 | 11.17 | -0.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -33.9% | -30.6% | 0.01 | 10.73 | -0.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -5.0% | -4.8% | 0.01 | 23.71 | -15.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 11.4% | -55.5% | -0.05 | 1.83 | -3.7 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 8.6% | -38.9% | -0.01 | 4.09 | -5.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -18.2% | 51.8% | -0.01 | 4.64 | 3.0 |